Clinical Trial Update: A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety of NNC0491-6075 in healthy volunteers and in individuals with dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• NNC0491-6075

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers, Dyslipidaemia | Phase 1 | Status: COMPLETED